ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
50 hedge funds and large institutions have $2.81M invested in Oncternal Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
50
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$83.6K | |
| 2 | +$60.9K | |
| 3 | +$18.3K | |
| 4 |
Renaissance Technologies
New York
|
+$7.89K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$6.37K |
Top Sellers
| 1 | -$203K | |
| 2 | -$10.2K | |
| 3 | -$9.79K | |
| 4 |
Two Sigma Advisers
New York
|
-$8.85K |
| 5 |
IIA
IPG Investment Advisors
San Diego,
California
|
-$8.17K |